Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Hemophilia A”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04286412
What this trial is testing

Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 25
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Large-scale testing (Phase 3)Study completedNCT01335061
What this trial is testing

Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 25
Testing effectiveness (Phase 2)Study completedNCT02396342
What this trial is testing

Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 10
Post-approval studies (Phase 4)Study completedNCT00243386
What this trial is testing

Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 82
Not applicableUnknownNCT03237273
What this trial is testing

HEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of Ultrasound

Who this might be right for
Moderate and Severe Haemophilia
Guy's and St Thomas' NHS Foundation Trust 200
Not applicableStudy completedNCT06191068
What this trial is testing

Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia

Who this might be right for
Hemophilia
The Hospital for Sick Children 190
Not applicableStudy completedNCT01034904
What this trial is testing

Health Related Quality of Life of Youth and Young Adults With Hemophilia A

Who this might be right for
Hemophilia A
CSL Behring 48
Post-approval studies (Phase 4)Active Not RecruitingNCT06752850
What this trial is testing

Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Who this might be right for
Haemophilia A (Moderate or Severe)Hemophilia, ClassicHaemophilia+3 more
Swedish Orphan Biovitrum 37
Post-approval studies (Phase 4)Study completedNCT02727647
What this trial is testing

Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients

Who this might be right for
Hemophilia A
Chulalongkorn University 16
Not applicableStudy completedNCT02362581
What this trial is testing

Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A

Who this might be right for
ProphylaxisHemophilia A
Chulalongkorn University 15
Not applicableStudy completedNCT05360706
What this trial is testing

Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

Who this might be right for
Hemophilia B
CSL Behring 9
Not applicableStudy completedNCT00703911
What this trial is testing

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 102
Not applicableUnknownNCT05628558
What this trial is testing

Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A

Who this might be right for
Hemophilia A, MildDesmopressinFactor VIII
Groupe Maladies hémorragiques de Bretagne 800
Early research (Phase 1)Study completedNCT01921855
What this trial is testing

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 16
Not applicableStudy completedNCT00195221
What this trial is testing

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Who this might be right for
Hemophilia BAllergic Reactions
Wyeth is now a wholly owned subsidiary of Pfizer 166
Large-scale testing (Phase 3)Looking for participantsNCT06716814
What this trial is testing

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

Who this might be right for
Haemophilia A (Moderate or Severe)
Swedish Orphan Biovitrum 104
Testing effectiveness (Phase 2)Study completedNCT00994929
What this trial is testing

Efficacy and Safety of IL-11 in DDAVP Unresponsive

Who this might be right for
Hemophilia AVon Willebrand Disease
University of Pittsburgh 9
Testing effectiveness (Phase 2)Looking for participantsNCT04676048
What this trial is testing

ASC618 Gene Therapy in Hemophilia A Patients

Who this might be right for
Hemophilia A
ASC Therapeutics 12
Large-scale testing (Phase 3)Study completedNCT00189982
What this trial is testing

Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Next Page